174 related articles for article (PubMed ID: 14598888)
1. The metalloproteinase inhibitor TIMP-2 is down-regulated by androgens in LNCaP prostate carcinoma cells.
Bratland A; Ragnhildstveit E; Bjørnland K; Andersen K; Maelandsmo GM; Fodstad O; Saatcioglu F; Ree AH
Clin Exp Metastasis; 2003; 20(6):541-7. PubMed ID: 14598888
[TBL] [Abstract][Full Text] [Related]
2. Androgen stimulates matrix metalloproteinase-2 expression in human prostate cancer.
Liao X; Thrasher JB; Pelling J; Holzbeierlein J; Sang QX; Li B
Endocrinology; 2003 May; 144(5):1656-63. PubMed ID: 12697668
[TBL] [Abstract][Full Text] [Related]
3. Regulation of mRNAs encoding MMP-9 and MMP-2, and their inhibitors TIMP-1 and TIMP-2 by androgens in the rat ventral prostate.
Limaye AM; Desai KV; Chavalmane AK; Kondaiah P
Mol Cell Endocrinol; 2008 Nov; 294(1-2):10-8. PubMed ID: 18675881
[TBL] [Abstract][Full Text] [Related]
4. Expression of matrix metalloproteinases (MMP-2, MMP-9, MT1-MMP) and their inhibitors (TIMP-1, TIMP-2) in common epithelial tumors of the ovary.
Sakata K; Shigemasa K; Nagai N; Ohama K
Int J Oncol; 2000 Oct; 17(4):673-81. PubMed ID: 10995877
[TBL] [Abstract][Full Text] [Related]
5. Expression of matrix metalloproteinase-2 and -9 and their inhibitors, tissue inhibitor of metalloproteinase-1 and -2, in primary cultures of human prostatic stromal and epithelial cells.
Wilson MJ; Sellers RG; Wiehr C; Melamud O; Pei D; Peehl DM
J Cell Physiol; 2002 May; 191(2):208-16. PubMed ID: 12064464
[TBL] [Abstract][Full Text] [Related]
6. Adenovirus-mediated expression of TIMP-1 and TIMP-2 in bone inhibits osteolytic degradation by human prostate cancer.
Deng X; He G; Levine A; Cao Y; Mullins C
Int J Cancer; 2008 Jan; 122(1):209-18. PubMed ID: 17847032
[TBL] [Abstract][Full Text] [Related]
7. Expression and activation of matrix metalloproteinase-2 (MMP-2) and its co-localization with membrane-type 1 matrix metalloproteinase (MT1-MMP) correlate with melanoma progression.
Hofmann UB; Westphal JR; Zendman AJ; Becker JC; Ruiter DJ; van Muijen GN
J Pathol; 2000 Jul; 191(3):245-56. PubMed ID: 10878545
[TBL] [Abstract][Full Text] [Related]
8. mRNA levels of membrane-type 1 matrix metalloproteinase (MT1-MMP), MMP-2, and MMP-9 and of their inhibitors TIMP-2 and TIMP-3 in normal thyrocytes and thyroid carcinoma cell lines.
Hofmann A; Laue S; Rost AK; Scherbaum WA; Aust G
Thyroid; 1998 Mar; 8(3):203-14. PubMed ID: 9545106
[TBL] [Abstract][Full Text] [Related]
9. Androgens stimulate fatty acid synthase in the human prostate cancer cell line LNCaP.
Swinnen JV; Esquenet M; Goossens K; Heyns W; Verhoeven G
Cancer Res; 1997 Mar; 57(6):1086-90. PubMed ID: 9067276
[TBL] [Abstract][Full Text] [Related]
10. Differential regulation of matrix metalloproteinase-9, tissue inhibitor of metalloproteinase-1 (TIMP-1) and TIMP-2 expression in co-cultures of prostate cancer and stromal cells.
Dong Z; Nemeth JA; Cher ML; Palmer KC; Bright RC; Fridman R
Int J Cancer; 2001 Aug; 93(4):507-15. PubMed ID: 11477554
[TBL] [Abstract][Full Text] [Related]
11. Differential localization of MT1-MMP in human prostate cancer tissue: role of IGF-1R in MT1-MMP expression.
Sroka IC; McDaniel K; Nagle RB; Bowden GT
Prostate; 2008 Apr; 68(5):463-76. PubMed ID: 18196535
[TBL] [Abstract][Full Text] [Related]
12. Differential expression of matrix metalloproteinases and their tissue inhibitors in human primary cultured prostatic cells and malignant prostate cell lines.
Zhang J; Jung K; Lein M; Kristiansen G; Rudolph B; Hauptmann S; Schnorr D; Loening SA; Lichtinghagen R
Prostate; 2002 Jan; 50(1):38-45. PubMed ID: 11757034
[TBL] [Abstract][Full Text] [Related]
13. Tissue inhibitor of metalloproteinases-4 inhibits but does not support the activation of gelatinase A via efficient inhibition of membrane type 1-matrix metalloproteinase.
Bigg HF; Morrison CJ; Butler GS; Bogoyevitch MA; Wang Z; Soloway PD; Overall CM
Cancer Res; 2001 May; 61(9):3610-8. PubMed ID: 11325829
[TBL] [Abstract][Full Text] [Related]
14. Androgens down-regulate the expression of the human homologue of paternally expressed gene-3 in the prostatic adenocarcinoma cell line LNCaP.
Ulrix W; Swinnen JV; Heyns W; Verhoeven G
Mol Cell Endocrinol; 1999 Sep; 155(1-2):69-76. PubMed ID: 10580840
[TBL] [Abstract][Full Text] [Related]
15. Roles of membrane type 1 matrix metalloproteinase and tissue inhibitor of metalloproteinases 2 in invasion and dissemination of human malignant glioma.
Nakada M; Kita D; Futami K; Yamashita J; Fujimoto N; Sato H; Okada Y
J Neurosurg; 2001 Mar; 94(3):464-73. PubMed ID: 11235952
[TBL] [Abstract][Full Text] [Related]
16. TIMP-2 (tissue inhibitor of metalloproteinase-2) regulates MMP-2 (matrix metalloproteinase-2) activity in the extracellular environment after pro-MMP-2 activation by MT1 (membrane type 1)-MMP.
Bernardo MM; Fridman R
Biochem J; 2003 Sep; 374(Pt 3):739-45. PubMed ID: 12755684
[TBL] [Abstract][Full Text] [Related]
17. Expression and localization of matrix metalloproteinases (MT1-MMP, MMP-2) and tissue inhibitor of metalloproteinase-2 (TIMP-2) during synepitheliochorial placentation of goats (Capra hircus).
Uekita T; Yamanouchi K; Sato H; Tojo H; Seiki M; Tachi C
Placenta; 2004 Nov; 25(10):810-9. PubMed ID: 15451196
[TBL] [Abstract][Full Text] [Related]
18. Progesterone differentially regulates the membrane-type matrix metalloproteinase-1 (MT1 -MMP) compartment of proMMP-2 activation in MG-63 cells.
Luo XH; Liao EY
Horm Metab Res; 2001 Jul; 33(7):383-8. PubMed ID: 11507673
[TBL] [Abstract][Full Text] [Related]
19. Role of tissue inhibitor of metalloproteinases-2 (TIMP-2) in regulation of pro-gelatinase A activation catalyzed by membrane-type matrix metalloproteinase-1 (MT1-MMP) in human cancer cells.
Shofuda K; Moriyama K; Nishihashi A; Higashi S; Mizushima H; Yasumitsu H; Miki K; Sato H; Seiki M; Miyazaki K
J Biochem; 1998 Aug; 124(2):462-70. PubMed ID: 9685743
[TBL] [Abstract][Full Text] [Related]
20. Analysis of tissue inhibitor of metalloproteinases-2 effect on pro-matrix metalloproteinase-2 activation by membrane-type 1 matrix metalloproteinase using baculovirus/insect-cell expression system.
Jo Y; Yeon J; Kim HJ; Lee ST
Biochem J; 2000 Feb; 345 Pt 3(Pt 3):511-9. PubMed ID: 10642509
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]